Gabrielle joined GARDP in September 2020 as Drug Safety & Pharmacovigilance Leader. She is responsible transversally of the safety aspects of all programs.
She started her career as a clinical data manager at Serono in Geneva in 2000. Two years later, she transitioned to ״Drug Safety and Pharmacovigilance״, which is her main domain of expertise and interest. After 8 years as Senior Pharmacovigilance Officer in various therapeutic areas, she was promoted Head of Medical Safety Evaluation (Neurology, Fertility & Rheumatology) at Merck Serono. She was heading a team of six Pharmacovigilance Officers, ensuring an adequate review of the clinical and post-marketing safety data, as well as the generation of regulatory documents for the drugs of the portfolio (mainly biotech medicines).
Following the closure of Merck Serono in Geneva in 2013, she took a one-year sabbatical to pursue a family project of sailing in the North Atlantic and the Caribbean. She taught primary school to her 2 daughters aged 6 and 8 during the whole year.
Back to Geneva, she joined GeNeuro early 2015. In this start-up developing a monoclonal antibody in multiple sclerosis, she was in charge of all safety activities for the compound and was providing support and advice to the clinical development team. She as well led the strategic alliance with “les Laboratoires Servier” which were funding clinical trials. As from 2019, she was also assigned a Quality Assurance role.
Pharmacist by education, Gabrielle holds a PhD in Pharmacology from the University of Geneva.